ping
PING
BTTT
For FYI
http://animalid.aphis.usda.gov/nais/index.shtml
Don't get me started on the Equine Passport!!
No NAIS graphic made by freeper devolve.
Thank you!
ping
Cross your arms like an X, in front of you, and keep repeating...'No, NAIS...No, NAIS', eventually they will understand. Making a sucking sound with your teeth closed will help also.
If it is for agriculture only, it may have a chance in passing. If it is for all animals, including pets, there will be a huge public outcry. Maybe we should work on getting pets included so there will be a huge publicity backlash.
I have been following this "Mark of the Beast" like program but do not have the time to put together a brief on it.
Once they have successfully tagged and numbered all the tens of millions of animals in the USA, they will point to NAIS' "success" and try to get us tagged and chipped as well.
NAIS is troubling on a lot of levels, but frankly the tactic of demonizing corporations such as Monsanto as a way of derailing its implementation is a transparent leftist ploy which is as intellectually bankrupt and disingenuous as chanting the mantra of Halliburton, Halliburton, Halliburton as a way of criticizing the Iraq war.
seems something you'd find of interest
Looks like someone may be trying to short Monsanto stock.
iie. That's how you say it in Japanese (in Romaji)
IG Farben (short for Interessen-Gemeinschaft Farbenindustrie AG) (and also called I.G. Farbenfabriken) was a German conglomerate of companies formed in 1925 and even earlier during World War I. Farben is German for "paints", "dyes", or "colors", and initially many of these companies produced dyes, but soon began to embrace more and more advanced chemistry. The founding of the IG Farben was a reaction to Germany's defeat in the First World War. IG Farben held a near total monopoly on the chemical production, later during the time of Nazi Germany. It is the German chemical firm that was the financial core of the Hitler regime, and was the main supplier of Zyklon-B to the German government during the extermination phase of the Holocaust. Before the war the dyestuff companies had a near monopoly in the world market which they lost during the conflict. One solution for regaining this position was a large merger.
IG Farben consisted of the following major companies and several smaller ones.
* AGFA
* Casella
* BASF (Badische Anilin und Soda Fabrik)
* Bayer
* Hoechst
* Huels
* Kalle
The I.G. Farben Building, headquarters for the conglomerate in Frankfurt/Main, Germany, was completed in 1931.
During the planning of the invasion of Czechoslovakia and Poland, IG Farben cooperated closely with the Nazi officials and directed which chemical plants should be secured and delivered to IG Farben.
In 1941, investigation exposed a "marriage" between Standard Oil Co. and I.G. Farben. It also brought new evidence concerning complex price and marketing agreements between duPont, a major investor in and producer of leaded gasoline, U.S. Industrial Alcohol Co. and their subsidiary, Cuba Distilling Co. The investigation was eventually dropped, like dozens of others in many different kinds of industries, due to the need to enlist industry support in the war effort. However, the top directors of many oil companies agreed to resign and oil industry stocks in molasses companies were sold off as part of a compromise worked out.
IG Farben built a factory for producing synthetic oil and rubber (from coal) in Auschwitz, which was the beginning of SS activity and camps in this location during the Holocaust. At its peak in 1944, this factory made use of 83,000 slave laborers. The pesticide Zyklon B, for which IG Farben held the patent and which was used in the gas chambers for mass murder, was manufactured by Degesch (Deutsche Gesellschaft für Schädlingsbekämpfung), a company owned equal 42.2 percent in shares by IG Farben and which had IG managers in its Managing Committee.
Of the 24 directors of IG Farben indicted in the so-called IG Farben Trial (1947-1948)c before a U.S. military tribunal at the subsequent Nuremberg Trials, 13 were sentenced to prison terms between 1½ and eight years.
Due to the severity of the war crimes committed by IG Farben during World War II and the extensive involvement of the management in the Nazi atrocities, the company was considered to be too corrupt to be allowed to continue to exist, and the allies considered confiscating all of its assets and putting it out of business. Instead, in 1951, the company was split up into the original constituent companies. The four largest quickly bought the smaller ones, and today only Agfa, BASF, and Bayer remain, while Hoechst merged with the French Rhône-Poulenc Rorer to form Aventis, now based in Strasbourg, France.
After the Holocaust, I.G. Farben joined with Americans to develop chemical warfare agents. Together they founded the "Chemagrow Corporation" in Kansas City, Missouri. The Chemagrow Corporation employed German and American specialists for the U.S. Army Chemical Corps. Dr. Otto Bayer was I.G. Farben's research director. He developed and tested chemical warfare agents with Dr. Gerhard Schrader.
In 1967, Monsanto entered into a joint venture with IG Farben.
Even though the company was officially liquidated in 1952, it continued to be traded on the Frankfurt Stock Exchange as a trust, holding a few real estate assets until it was finally declared bankrupt on November 10, 2003 by its liquidators, after contributing 500,000 Deutschmarks (160,000 British pounds or 233,000 American dollars) towards a foundation for former slave laborers under the Nazi regime and the remaining property, worth 21 million Deutschmarks (6.7 million British pounds or 10 million American dollars) going to a buyer. During this lengthy period, the holding company had been continually criticized for failing to pay any compensation to the slave laborers, which was the stated reason for its continued existence after 1952. The company, in turn, blamed the ongoing legal disputes with the former slave laborers as being the reason it could not be legally dissolved and the remaining assets distributed as reparations. Each year, the company's annual meeting in Frankfurt was the site of demonstrations by hundreds of protesters.
David W. Beier . . .former head of Government Affairs for Genentech, Inc., . . .now chief domestic policy advisor to Al Gore, Vice President of the United States.
Linda J. Fisher . . .former Assistant Administrator of the United States Environmental Protection Agency's Office of Pollution Prevention, Pesticides, and Toxic Substances, . . .now
Vice President of Government and Public Affairs for Monsanto Corporation.
Michael A. Friedman, M.D. . . former acting commissioner of the United States Food and Drug Administration (FDA) Department of Health and Human Services . . .now senior vice-president for clinical affairs at G. D. Searle & Co., a pharmaceutical division of Monsanto Corporation.
L. Val Giddings . . . former biotechnology regulator and (biosafety) negotiator at the United States Department of Agriculture (USDA/APHIS), . . .now Vice President for Food & Agriculture of the Biotechnology Industry Organization (BIO).
Marcia Hale . . . former assistant to the President of the United States and director for intergovernmental affairs, . .
.now Director of International Government Affairs for Monsanto Corporation.
Michael (Mickey) Kantor. . . former Secretary of the United States Department of Commerce and former Trade Representative of the United States, . . .now member of the board of directors of Monsanto Corporation.
Josh King . . . former director of production for White House events, . . . now director of global communication in the Washington, D.C. office of Monsanto Corporation.
Terry Medley . . . former administrator of the Animal and Plant Health Inspection Service (APHIS) of the United States Department of Agriculture, former chair and vice-chair of the United States Department of Agriculture Biotechnology Council, former member of the U.S. Food and Drug Administration (FDA) food advisory committee, . . . and now Director of Regulatory and External Affairs of Dupont Corporation's Agricultural Enterprise.
Margaret Miller . . . former chemical laboratory supervisor for Monsanto, . . .now Deputy Director of Human Food Safety and Consultative Services, New Animal Drug Evaluation Office, Center for Veterinary Medicine in the United States Food and Drug Administration (FDA).*
Michael Phillips . . . recently with the National Academy of Science Board on Agriculture . . . now head of regulatory affairs for the Biotechnology Industry Organization.
William D. Ruckelshaus . . . former chief administrator of the United States Environmental Protection Agency (USEPA), . . .now (and for the past 12 years) a member of the board of directors of Monsanto Corporation.
Michael Taylor . . . former legal advisor to the United States Food and Drug Administration (FDA)'s Bureau of Medical Devices and Bureau of Foods, later executive assistant to the Commissioner of the FDA, . . . still later a partner at the law firm of King & Spaulding where he supervised a nine-lawyer group whose clients included Monsanto Agricultural Company, .
. . still later Deputy Commissioner for Policy at the United States Food and Drug Administration, . . . and later with the law firm of King & Spaulding. . . . now head of the Washington, D.C. office of Monsanto Corporation.*
Lidia Watrud . . . former microbial biotechnology researcher at Monsanto Corporation in St. Louis, Missouri, . . .now with the United States Environmental Protection Agency Environmental Effects Laboratory, Western Ecology Division.
Jack Watson. . .former chief of staff to the President of the United States, Jimmy Carter, . . .now a staff lawyer with Monsanto Corporation in Washington, D.C.
Clayton K. Yeutter . . . former Secretary of the U.S. Department of Agriculture, former U.S. Trade Representative (who led the U.S. team in negotiating the U.S. Canada Free Trade Agreement and helped launch the Uruguay Round of the GATT negotiations), now a member of the board of directors of Mycogen Corporation, whose majority owner is Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company.
Larry Zeph . . . former biologist in the Office of Prevention, Pesticides, and Toxic Substances, U.S. Environmental Protection Agency, . . . now Regulatory Science Manager at Pioneer Hi-Bred International.
*Margaret Miller, Michael Taylor, and Suzanne Sechen (an FDA "primary reviewer for all rbST and other dairy drug production applications" ) were the subjects of a U.S. General Accounting Office (GAO) investigation in 1994 for their role in the U.S. Food and Drug Administration's approval of Posilac, Monsanto Corporation's formulation of recombinant bovine growth hormone (rbST or rBGH). The GAO Office found "no conflicting financial interests with respect to the drug's approval" and only "one minor deviation from now superseded FDA regulations". (Quotations are from the 1994 GAO report).
http://www.freerepublic.com/focus/f-chat/1579642/posts
Who benefits from GM crops?
ping
http://www.freerepublic.com/focus/f-news/1382595/posts
Deadly Flu Strain Shipped Worldwide
Excerpt:
By Rob Stein and Shankar Vedantam
Washington Post Staff Writers
Wednesday, April 13, 2005; Page A01
A dangerous strain of the flu virus that caused a worldwide pandemic in 1957 was sent to thousands of laboratories in the United States and around the world, triggering a frantic effort to destroy the samples to prevent an outbreak, health officials revealed yesterday.
Because the virus is easily transmitted from person to person and many people have no immunity to it, the discovery has raised alarm that it could cause another deadly pandemic if a laboratory worker became infected, officials said.
Naisu wa, Iie!